Theranos Says Investors Can't Sue Over Blood Tests
By Dorothy Atkins · March 1, 2017, 9:14 PM EST
Beleaguered blood-testing startup Theranos and its executives urged a California federal judge Wednesday to toss a putative securities class action alleging they misled investors about the accuracy of Theranos' tests, saying...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login